This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Teja Muralidhar Kalidindi: Innovator in Cancer Detection and Treatment
Introduction
Teja Muralidhar Kalidindi is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer research, particularly in the development of novel therapeutic agents. Her work focuses on improving the detection and treatment of PSMA positive cancers.
Latest Patents
Teja holds 1 patent for her invention titled "Theranostic agents for PSMA positive cancers." This patent provides compositions and methods for the detection and treatment of cancer. The technology includes novel radiohalogenated PSMA targeting agents, which are utilized in diagnostic imaging and radiation therapy.
Career Highlights
Teja Muralidhar Kalidindi is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. Her work at this prestigious center has allowed her to contribute to groundbreaking advancements in cancer therapy.
Collaborations
Teja collaborates with esteemed colleagues, including Naga Vara Kishore Pillarsetty and Serge Lyashchenko. These partnerships enhance her research efforts and contribute to the development of innovative cancer treatments.
Conclusion
Teja Muralidhar Kalidindi is a dedicated inventor whose work in cancer detection and treatment is making a significant impact in the medical field. Her innovative approaches and collaborations are paving the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile